In short
Fast Money (5/6/25) covers a broad market rally tied to Middle East optimism and an AI-driven chip surge. Topic: NVIDIA’s effect—NVIDIA announced a $500M investment in Corning, lifting Corning and other chip/AI infrastructure names; debate why NVIDIA is still lagging the broader semi/mega-cap rally and whether the AI trade is early innings or near a “next year” multiple hurdle. Markets: Dow above 50K briefly; oil (WTI) down on hopes of a U.S.-Iran deal (14-point proposal; possible sanctions/frozen funds release; reopening Strait of Hormuz). Other segments: Disney’s Q1 under new CEO Josh DiMero; Joby Aviation eVTOL update (pre-cert, passenger ops targeted late 2026); Novo Nordisk oral Wegovy momentum; McDonald’s options positioning ahead of earnings.
Guests
Gene Munster (Deepwater Asset Management; AI/tech investor); Peter Bookvar (One Point BFG Wealth Partners; market/technical analyst); Tom Rogers (Versant Media/CNBC founder; media executive); Mizuha (healthcare specialist at Holstier); Jared Holtz (healthcare investor/analyst).
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Chapters
Tap a time to open that second in VOMarket Overview and Major Indices
1:40 to 2:17
Discussion on the rally in markets, particularly the Nasdaq and S&P 500.
“And surprise, surprise, a pop-in from Gene Munster, Deepwater Asset Management.”
NVIDIA's Investment in Corning
2:18 to 2:56
Exploring NVIDIA's investment in Corning and its impact on the market.
“But we start off with the latest tie-up, sending chip stocks higher.”
Analysis of NVIDIA's Stock Performance
2:57 to 4:25
Panel discusses NVIDIA's stock performance and market position.
“The stock is finally catching up on this chip rally.”
Future Prospects for AI and NVIDIA
4:26 to 6:30
Insights into the future of AI and NVIDIA's potential in the market.
“When we think about our investments within MegaCap, we look for companies that can have a changed narrative.”
Market Influences and Industry Dynamics
6:31 to 11:15
Discussion on the current market dynamics and industry trends, including software.
“Everyone NVIDIA is investing in hasn't popped yet?”
Potential Impact of Iran Deal on Markets
11:16 to 14:00
Analysis of how potential peace deals in Iran may influence global markets.
“The more hype you can get, great, the better.”
Market Reactions and AI Trade Insights
14:00 to 19:31
Discussion on crude oil prices, market dynamics, and the AI trade impact.
“So he said, quote, we'll see what happens.”
Meta's Position and Investment Strategy
19:31 to 21:20
Analysis of Meta's stock position and its comparative performance in the market.
“Meta has also been sort of sitting out of this party.”
Disney's Performance and Future Strategies
22:56 to 28:01
Insights into Disney's earnings, challenges, and the role of AI in content creation.
“Disney shares leading the Dow today, jumping almost 8 percent.”
Disney's Streaming Success
28:01 to 30:13
A discussion on Disney's recent financial performance and competitive landscape.
“But that level of sophisticated AI use that's going to generate incredibly high quality at incredibly low cost is right around the corner.”
Show all 19 chapters
Joby Aviation's Earnings Report
31:20 to 33:26
Analysis of Joby Aviation's financial performance and market position.
“Last night, the electric vertical takeoff and landing company, EBTOL, did see a bigger loss than expected for the quarter.”
Market Reactions to International Developments
33:26 to 36:51
Exploration of how international relations impact global stock markets.
“Stocks surging and oil pulling back on optimism the U.S.”
Novo Nordisk and Wegovi Pill Sales
36:51 to 37:35
Discussion on the impact of Wegovi on Novo Nordisk's sales and market position.
“But the flip side of it is that a lot of these areas, like the things that Karen's invested in, have already been compressed themselves so much that I kind of feel like that damage is baked into the cake.”
Future Prospects for Novo Nordisk
37:35 to 42:00
Insights on Novo Nordisk's future strategies and market performance.
“Novo Nordisk rising 2 % after reporting strong Q1 sales bolstered by its Wegovi pill.”
Discussion on Novo's Treatment Approach
42:00 to 43:30
Insights into Novo's peptide vs small molecule treatment decision and market impact.
“I don't have like a, you know, a name that they need to be buying.”
Investor Sentiment on Novo's Stock
43:30 to 43:51
Discussion on the current investment sentiment and purchasing decisions regarding Novo's stock.
“But, I mean, it's still got a long, long way to go.”
Analysis of McDonald's Earnings Expectations
43:56 to 45:49
Evaluating McDonald's stock performance and options trading activity leading to earnings.
“We are setting the table for McDonald's earnings tomorrow before the open.”
Final Trades and Market Strategies
45:49 to 46:52
Participants reveal their final trades and broader market strategies.
“I mean, at some point you think if a consumer is really under stress, maybe you go to McDonald's.”
Final Trades and Market Strategies
47:29 to 48:57
Participants reveal their final trades and broader market strategies.
“ZetBound is approved as a 2.5, 5, 7.5, 10, 12.5, or 15 milligram injection.”
Transcript
Automatic transcript. May contain errors.0:00Say you always wanted to have a backyard oasis. Here's the thing. If you get smart with your money, you can do things like that. With Empower, you can start making the most out of your money so you can go out and live a little. Isn't that why we work so hard? To have some fun with our money? Like treating yourself to something special or spontaneously doing something extra for a loved one. So use Empower and get good at money so you can be a little bad. Join their 19 million customers today at Empower.com. Not an Empower client paid or sponsored. At Venture Global, we think about what can be done, not what's usually done.
0:36Through innovation, Venture Global is not only building some of the largest energy facilities in the world right here in the United States, but delivering American energy at a fraction of the cost and a fraction of the time. So while others are busy talking, we're busy building. That's Venture Global. That's unstoppable energy. Live from the Nasdaq market site in the heart of New York City's Times Square, this is Fast Money. Here's what's on tap tonight. The NVIDIA effect. Partnerships with the chip giant have sent shares of companies like Corning, Firefly and others soaring. So why are NVIDIA shares only now joining the party?
1:15We'll debate that. And going global, it's not just U.S. equities in rally mode today from Germany to Japan to China. We dig in on the international moves and where you can find opportunity right now. Plus, shares of Novo Nordisk hit nearly three-month highs. A solid start for Disney's new CEO. and counting down to McDonald's earnings. Will investors be loving on the burger chain results tomorrow? We are heading to the options pits to find out. I'm Melissa Lee. Come to you live from C. Duby at the NASDAQ. On the desk tonight, Karen Feinerman, Steve Grasso, Mike Coe on set for the hour. And surprise, surprise, a pop-in from Gene Munster, Deepwater Asset Management.
1:49He was in town visiting, happened to come through the NASDAQ, and now he's sitting on set with us here on Fast Money. Welcome, Gene. Great to be here, Melissa. Markets in rally mode once again today with the Nasdaq and S &P 500 notching another set of records. Dow adding more than 600 points, briefly trading above the 50K mark for the first time since February. The latest move coming as oil prices continue to pull back. WTI crude falling below$90 a barrel at its lows on hopes of resolution to the Iran wars in sight. We'll get more on that in just a minute. But we start off with the latest tie-up, sending chip stocks higher.
2:21NVIDIA announcing it will invest half a billion dollars in Corning. The news sending the fiber optics maker to record highs, giving NVIDIA more than 5 % bump. It was NVIDIA's best day in three months, but interestingly, only gets it back to where it was last week. The chip giant, in fact, has been underperforming the broader semi-space mega cap tech and major indices over multiple timeframes. It's gained in the past month less than half that of the SMH, even though it's got market cap of$5 trillion, so the biggest company in the world. At 25 times forward earnings, NVIDIA is actually cheaper than the likes of Intel.
2:54AMD and Broadcom. So is today's move a sign? The stock is finally catching up on this chip rally. How do you trade the name right now? Karen, what's your answer? Yeah. So I'm long. I've been long for a long time. I actually bought some butterflies today, some sort of bull butterflies. Mike would probably maybe have been the seller, in which case that wasn't good. So good for me. But anyway, I mean, I agree. It's just sort of absurd that everything around it, everything it touches trades at a wildly different level of hype or a much higher P.E. And, you know, two weeks from today, we'll see. They'll report.
3:28I'd rather they go in with somewhat subdued performance, right? The blower the bar, the better. I think the quarter will be enormous. That won't be shocking to anyone. But it's very odd how it trades this way, given, you know, it is the center of everything. Now, what is your take on what is going on here? I think the issue is what next year is going to look like. And the street right now is looking for CapEx and the hyperscalers to be up 10%. NVIDIA talked about a 40 % growth rate for next year. That's what Jensen's comments were recently at their developer conference. And my take, Melissa, is that I think the issue here is that it's just hard for investors to get over this hurdle that the party's going to end soon.
4:09And so we actually, we're big believers, and we're still early second inning of AI. but we actually sold some of our NVIDIA recently just because we felt like the news is going to be great, but there's always this next year, next year, next year. We don't know what's going to kick that. One last piece. When we think about our investments within MegaCap, we look for companies that can have a changed narrative. And NVIDIA, there's no opportunity for them to change the narrative. Apple can change the narrative to be incompetent in AI. And in the case of NVIDIA, the narrative is very positive. It's just hard to get that incremental turn on the multiple.
4:45Whereas like an Intel, CPUs are now important and in shortage memory. It's now subscription memory. So that whole model has changed. What's your take? Yeah, I mean, we own NVIDIA. We continue to. We have it in several funds. You know, we have not been adding to it of late. You know, it's not expensive in my view. And I kind of feel like you sort of have to stay in it. They've got proprietary technology is our thinking. There's a lot of other things that if you simply looked at the multiple, you would say, oh, these things look very cheap, but they have typically been commodities. So we have exposure to other areas as well, including Intel and Taiwan and all the rest of it, and Micron even.
5:25But I think that NVIDIA's proprietary technology is the reason we stay in the name. So who would be the buyer if this thing is going to go higher right now? Everyone who wants to own NVIDIA? Well, if it gets cheap enough. I mean, because you have some large institutions. So I traded for 55 of the largest institutions most of my career. If they own it, they're slow to sell it. They're not quick to buy more. Right. So, yes, if it gets cheap enough and it loses a certain percentage in their fund, then they're going to buy it. I don't I don't think that's the case at this point. We haven't seen that.
5:59You see the retail investor buy it. They're not enough to move this ship where where it is. I think Gene touched on it. The run in the stock has already been there, right? In 2022, the stock was trading at$16. So when you look at it, when you think of it as a gaming stock, and then they did morph into recently with the sovereign investments. So they have changed it. And then the investments all around the street. So everybody who they're investing in hasn't popped yet. That's where the alpha is going to be. So you're going to leave. Everyone NVIDIA is investing in hasn't popped yet? Did Corning?
6:34Right. So Corning, I'm talking about that investment right now. Like anyone that's going to that you're really going to see that like Caterpillar is an A.I. stock now. So that's going to rally even though it's been rallying, but it's going to rally on the A.I. data center build out. Corning is going to be rallying because if they put them in their racks, you throw out the copper, you put in the fiber. Now, that could be exponential changer for a Corning. Isn't it exponential changer for an Nvidia? No. So that goes to James theory, you know, that that it's the narrative that's not changing for NVIDIA back in the time that you're saying.
7:07Yeah. When it actually wouldn't remember when they had that huge revenue increase. Right. And that's that's when the narrative change for that stock. That's where the the best gains for NVIDIA happened after that time period. And so now, yeah, to your point, it's not. But everybody else's narrative is changing. Everybody else's narrative is changing. I would say that there's an important dynamic to all this, too. And I still think NVIDIA is a great company. But the one narrative that is consistent but still underappreciated is how early we still are. And I just want to quickly mention the anthropic news last night.
7:38That was huge news relative to this deal with Google. And then separately, what they just announced tonight with SpaceX about more compute. Why is that happening? The reason why that's happening is the demand for these models. We're using them is going up exponentially. And so I think that there is a narrative around the broader AI trade that is going to be consistent, but even get stronger. And it comes to NVIDIA. I just think that wall of worry is just going to nag the stock here. But think about in the early innings, right, in the early innings of this, NVIDIA had no competition. Now they have all of their clients are their biggest competition and they've got the normal competition that's out there.
8:17No one would have ever thought AMD is their competition. Now AMD is in their lane. So they went from in the early innings, zero competition to a herd of competition in the later innings. Could it still run? Yes. Is it going to run the same way it did? I don't think so. The next incremental dollar that comes into the market, where does most of it go? Most of that is going into NVIDIA. I mean, capital inflows into the market are going. But I mean, look at most managers. I mean, I think the closet indexers. I mean, if they go into SPY, if they go into the S &P 500, the incremental dollar goes more into NVIDIA than anything else.
8:54First of all, Corning is up, what, fourfold in the last 52 weeks or so? So, I mean, I would have to disagree that that hasn't seen a run. I mean, it's run a lot more than NVIDIA has. Compared to NVIDIA from the beginning of this, from a teenager, from all the hype. I'm just talking about the last 52 weeks. Okay. All right. Let me have one other perspective here. Two years ago, the issue with AI, with getting this going, was all about capacity and GPUs. And that's what NVIDIA, the breathtaking move in the stock was. Now it's about power. It's about infrastructure. It's about optics. Like that incremental dollar, to your point, like the incremental dollar, NVIDIA is getting it.
9:29But that's not where the majority of those incremental dollars are now going to this other, this infrastructure around it. I think there's still a big opportunity relative to that infrastructure trade. So when we take a look at the disparity between the valuation of NVIDIA and the rest of the semi-trade that has been re-rated higher, are those re-ratings in process? I mean, is there still more upside to go? I would just say, like, I'll leave with a couple of fun predictions here. One is that we're still grossly underestimating how big this whole AI trade is going to be. A second is like one little flavor around that.
10:05is just to let's look at Apple. Let's make the prediction that next year it's going to be hard to get a MacBook. I think it's going to be hard. I think what people are doing with co-work and codex on their laptops right now, I think those are types of ripples that the market's not quite thinking about right now. So then my next question, and I'll pose it to you since you're next to you. Why not? If the AI trade is getting stronger in terms of memory, I mean, is the inverse trade, software will die again? Like, will we be in that sort of, you know, paradigm again? Because what we saw in today's session was semis very strong, particularly these areas that are viewed as shortages or constraints or bottlenecks or whatnot.
10:49And then we saw software just flat, weak, Microsoft weak. I mean, it continues here. I think so. I mean, I think part of the part of the cesspocalypse theory is fewer seats, for example, fewer, less pricing power. And I think that there absolutely is going to be survivors, but I do think those things will weigh on the industry for a while. So that I think is here to stay. The thing though, I want to also say about NVIDIA though, it's not, it's all upside right now at the moment. Everything's frenzy. The more hype you can get, great, the better. If that turns around, I would rather be in NVIDIA than everything else.
11:29And one other thing that Lisa Su, I'm sure you all saw her piece today with Jim, talking about the monumental change in what they thought the ratio of GPUs to CPUs was, right? And, you know, I think that NVIDIA could absolutely participate in that as well. So I'm a little perplexed that it's not trading better. I mean, if you look at software, just how the stocks are performing, names like Microsoft are still well off their highs. They're still well below their long-term moving averages. This is an area that continues to be, even though they got a little bit of a bid today, continue to be under some pressure.
12:08What do you think about the software sector? Pretty negative on software. I think, Karen, when you said that, you know, the headcount, less knowledge workers. By the way, when we talk about less knowledge workers, let's just not talk about them, about students in college going to the workforce. It's people like me who's at risk care, too. And there are going to be a lot of jobs that unfortunately are going to be lost. If we look at the ADP numbers from today, 109 ,000, 64 ,000 for education, health care, 25 ,000 construction and transportation. The growth is not coming from knowledge worker. And I think that's the most basic piece.
12:42It's hard for me to imagine these software companies working if we have less knowledge workers. All right. Well, let's get to back to the rally in the broader markets on potential progress in an Iran deal. CNBC's Megan Cassell has got the very latest there. Megan. Melissa, there's reason for optimism here today that the U.S. and Iran could be moving closer to a peace deal, as the Iranians say they're evaluating a 14-point proposal from the U.S. Now, the details of the proposal aren't entirely clear, but the gist of it, according to reports, is that it would center on a one-page memo to end the war and then would launch 30 days of negotiations on the more difficult issues, including Iran's nuclear program.
13:17Now, President Trump said today that the U.S. would get Iran's highly enriched uranium as part of this plan and and that Iran would stop operating its underground facilities, enrichment facilities, missile storage, that sort of thing. Axios and others have also reported that the deal includes a reopening of the Strait of Hormuz, and that the U.S. would then lift sanctions and release billions of dollars in frozen Iranian funds in exchange. But two big caveats here. Iran has not yet agreed to any of this, and some of it, including the export of highly enriched uranium, has been a red line for them in the past.
13:46President Trump has also long been critical of the loosening of sanctions and the unfreezing of funds dating back to the Obama deal, So we'll have to see the details of that piece of it as well. I'd sum it up this way. The president said today that he feels optimistic that the U.S. is closing in on a deal. But he also said that he's felt that way before. So he said, quote, we'll see what happens. Melissa. All right. Megan, thanks. Megan Casella. Crude oil prices dropping more than 7 percent on hopes of an Iran deal. But our next guest says don't expect a return to$64 oil anytime soon. CBC contributor One Point BFG Wealth Partners Peter Bookvar joins us now.
14:19Peter, great to have you with us. Hi, Melissa. First, I just want to get your take on the market. I mean, I was sort of joking with Mike Santelli the last hour, you know, what's going to happen when the war actually ends? And we said probably fall. I mean, I don't know. What are your thoughts? Well, the war is going to end trade really started in early April and then was furthered by the actual ceasefire and has just obviously been roaring ever since, of course, helped by the AI trade, particularly semis. I mean, I'm just in awe of this move in semis. I look at my crunch from a technical perspective, having no opinion on the stock here, trading at 135 % above its 200-day moving average.
15:02The SOX in March 2000 peaked at 100 % above its 200-day moving average. The NDX, the 14-day RSI, closed at its highest level since 2024. So it's just been unbelievable. And I guess that begs the question, OK, when the war actually does end and there's confirmation in the street reopens, do we just keep on going? Yeah, I guess that's a big unknown. Peter, I'm just wondering, I mean, you're a smart market guy. We've known you for a long time. I mean, are you skeptical of the AI trade or do you believe in it? Because if you believe in it, then why is it so unfathomable that micron trades where it trades?
15:43And do you think that the oil situation in terms of if the war ended today, we'll still be in shortage in terms of we'll have to restock reserves? There's going to be an amount of time before production gets back to where it was. I mean, there's a sort of recovery time that maybe we're not factoring in here. Does that A.I. trade get dismantled or disrupted because of that? So with six hundred and eighty billion dollars expected to be spent this year on A.I., it's for real. However, the one thing that I would caution here is from what I am hearing in all the PMIs, I particularly heard it from CDW today, whose stock fell 20%.
16:24This company sells software, hardware, services throughout the entire tech ecosystem. They specifically said they are seeing their customers front-running orders ahead of price increases and worries about supply shortages. So I'm pretty confident that you are seeing a lot of double and triple ordering on fears that companies are not going to get what they need. Now, the market is not thinking that right now, but that's the one caveat I have to this move higher in this trade. Are you thinking that, Gene? I'm curious. No, I'm not. I'm just, from my perspective, it comes down to what's the utility of AI today?
17:06How many companies can tangibly say that this is having a big impact on their business? And there's two. It's Google with search and outside of the cloud, and it's meta with their advertising businesses. And when the argument that we're somehow reaching a top here just doesn't jive with what we're seeing in the pace that these companies are trying to implement and the fact, the reality of how early. Again, come back to if we look at one example, physical AI piece. Autonomous ride shares between Waymo and Tesla, Lyft and Uber, it'll be 2 % of the total miles driven this year. I mean, we're still scratching the surface.
17:43And so I understand that's a well-traveled topic. We're still scratching the surface. But I think it's actually contrarian right now to be bullish on the AI trade. So, Peter, back to you. You don't have—it sounds like you have questions about how solid the AI trade is, and it's obviously right now a big driver of the market. So are you skeptical where the markets are right here in terms of valuations, in terms of level, and are we just destined for a sort of reckoning? I mean, a market that's led by semis, eventually you do hit a reckoning. But for all I know, it can be 2027 before that actually happens.
18:25I mean, the market is differentiating amongst the tech trade. Gene talked earlier about weakness in tech. I'm sorry, weakness in software. We're seeing a bifurcated MAG-7 because the excessive spenders like Meta, for example, are getting hurt while the receivers of that spend are benefiting tremendously. So it's sort of like this three-pocket tech trade. And it depends on which that you're in will determine how your stock is going to trade with the obvious beneficiary, those that are saying, OK, show me that$680 billion. They're doing the best. Now, of course, we'll overdo it. And I mean, I've been doing this long enough to know that storage and memory are the most cyclical parts of the market.
19:12And I know people are telling me, oh, well, this time is different. It's an oligopoly. And maybe maybe the case. I just know that it's a commodity that they're selling. Eventually, this will hit a wall. But right now, it's party on. Peter, always great to speak with you. Thank you. Thanks, Melissa. Peter Brookbart. Peter mentioned Meta. Meta has also been sort of sitting out of this party. Karen, Meta is a large position of yours. It is. Google and Amazon are larger now, both from decreasing Meta, but also Meta decreasing itself, which isn't delightful. But, I mean, if they were to come out tomorrow and say, that's it, we give up, right?
19:52Does the stock rally? Absolutely. It goes nuts, I think. So I understand what he's saying. Although Google, you could say they are, I mean, they're both. They're spending and they're growing and it's worth it. And they're selling chips and they're selling cloud. And I come back again and again to Andy Jassy talking about, this is not a hypester kind of guy, talking about the extraordinary opportunity. They've never seen anything like it. I want them spending that money. We know that it's working for the underlying part of Meta's business, right? The advertising is doing great, although that's kind of tempered guidance for the next quarter.
20:25But, you know, there's a fear. There's so many giant spenders out there. Not every single one is going to get the return on capital that they need. Right. Gene, quick last thoughts on Meta. Meta, we recently sold out. We still own Google, Amazon, Apple. and from our perspective, it's just that incremental piece wasn't there. 33 % growth down to 28%, like you mentioned. Better places to be. All right. Gene, it's great to see you in person. Thanks for having me. Super fun. What a lucky coincidence. You happened to walk through the NASDAQ. We thought it was just AI. We didn't think he existed. It's a real Gene Munster here.
21:01All right. See you next time, Gene. Who else is downstairs? I don't know. We'll find out. Coming up, a touch of magic for Disney. The results feeling the media giants jump today and the stage it set so early in Josh DiMero's tenure, plus shares of Joby taking off all the details from the eVTOL company's latest report and when you can expect to catch a ride, if you want to catch a ride. Don't go anywhere fast when he's back in two.
21:26Comcast is delivering extraordinary experiences in live sports through the incredible broadcast and storytelling from NBC, innovative and personalized viewing features on Xfinity and Peacock and the country's most reliable Wi-Fi, viewers can enjoy every game-changing play faster and more seamlessly than ever. All on a network built to deliver unforgettable moments as close to live as possible. The ultimate experience for the American sports fan. Learn more at comcastcorporation.com slash sports. Never bet against American grit or American energy. Through innovation, Venture Global is not only building some of the largest energy facilities in the world right here in the United States, but delivering American energy at a fraction of the cost and a fraction of the time.
22:15So while others are busy talking, we're busy building. That's Venture Global. That's unstoppable energy.
22:27The Second World War is the largest event in human history. A 20-part documentary series with Tom Hanks. No part of the globe was untouched. No life unchanged. Experience the ultimate account of World War II. Every single person had a story. These are the stories that make us who we are. World War II with Tom Hanks. New episode, Monday at 8. Part of History Honors 250. Only on the History Channel. Welcome back to Fast Money. Disney shares leading the Dow today, jumping almost 8 percent. The media giant posting better than expected revenues driven by strength in its parks and streaming businesses.
23:07It was the company's first earnings report under new CEO Josh DiMero. CNBC founder and current contributor Tom Rogers joins us with his reaction. Tom was the first president of NBC Cable and is now senior advisor to CNBC's parent company, Versant Media. Tom, always great to have you with us. Thanks for having me. So a great first quarter for a CEO. He didn't kitchen sink it. Did you like his message that he wants to be more impactful when it comes to the fans who come to Disney? You can't disagree with the message. Of course, they want the company to be more impactful. I think his idea of having Disney Plus serve as a broader portal of some kind to share the wealth of Disney across all the individual silos it has to bring people in to experience more of Disney than they may currently do.
23:57But that's a building process. They first got to get the putting together of Disney Plus and Hulu right to make sure that those two sites coming together as services really have the kind of personalized recommendation and user interface that it needs. They've had some success bringing ESPN into a bundle and lowering churn for all the Disney services, which was not very enviable when they were all man for themselves with each service. But I think they've got to do better than that and really show how sports contributes to making a family bundle of Disney general entertainment, kids entertainment, sports all in one in a cohesive way that really shows that it's a destination in the streaming world that you want to stay at.
Read the full transcript
24:48The problem with all that is they're still weak on engagement. It's great to combine sites and have a wealth of programming there, but they really have been pretty flat when it comes to viewership. And actually, YouTube has overtaken Disney in terms of total company viewership. And when Paramount, Warner finally come together, they will probably have greater total viewership even than YouTube. And Disney hasn't used that broader company viewership to really drive engagement that well. To do that, you need more general entertainment programming. The problem is they got two big mouths to feed. They got to feed the capital expense, 60 billion of parks and cruises.
25:31And they got to feed this sports beast, which is almost half their total content spending, about to get even more when the NFL renegotiation goes through. And in their general entertainment programming needed to drive engagement is going to get squeezed. And that's where AI comes in. Right. So yesterday on Squawk Box, you were saying that they really need to have a new franchise to sort of build off this flywheel. Do they need a lot of money to do that now? Or is it possible with AI that that spend on a new franchise is actually less than it had been in the past? Well, and there's another great balancing act with all their entertainment programming.
26:09How much can they spend on broader entertainment that isn't really geared coming up with those new franchises? They mentioned Zootopia 2. how well it's done, clear examples of some, but they need more of those. They really haven't had great franchises. And I'm always amazed that Bluey, a acquisition, is by far the biggest show on Disney +, not being produced by Disney at all. I think what AI can do is provide general entertainment programming at a high, high quality level, at incredibly lower cost. We haven't seen it yet. it's going to be shown this year. It's imminent. It's going to happen. And the industry as a whole is going to have to grapple with it.
26:54Because on the one hand, it helps deal with the need for general entertainment programming, where you have two other mouths that feed that skip in those budgets. But on the other hand, it lowers the competitive advantages that the Disneys and the Netflix have if you can have terrific high quality programming, but not need the big budgets in order to access that program. Sure. Maybe this is a Disney-related question, maybe not, Tom. But how far are we, do you think, from the day when a kid can speak into an iPad or a TV and say, I want a show about a baby elephant and a pink rabbit going to the circus and meeting a mouse, and then it gets generated?
27:37You can do that today, and most people think the quality of it is slop. But what you will find, I think imminently, is some pretty sophisticated building on those video models that generate that stuff today that refine the outputs in a way that create something that is indistinguishable from the best Hollywood productions. And that's beyond a single kid coming out of college. But that level of sophisticated AI use that's going to generate incredibly high quality at incredibly low cost is right around the corner. Wow. Tom, it's always great to speak with you. Thank you. Thanks for having me. Tom Rogers, what did you make of Disney?
28:20So when you look at their operating income from streaming and it jumps 88 percent, I think that's the that's the tell. They've somehow overnight become profitable and figured out the secret weapon as to how to turn that up a notch or two notches. Their margins drastically jumped above 10. And they said that's the floor. So if the margins, the floor is going to be 10 only upside. Operating income is up. I think it's still a buy. Mike, you know, sports were absolutely one of the reasons that Disney was a marquee property for the longest time, thanks to ESPN. And, you know, we've seen the top line come in as a result.
28:58And now they are competing with the likes of YouTube. Very deep pockets and a very compelling offering. I can tell you that we see a lot of sports in our own house on YouTube where you can watch four games at once. And that is a capital, you know, intensive business as much as the parks and boats are, too. You have to compete with Alphabet now. That's a tough competitor if you're going to spend money. Coming up, shares of Joby lifting off after the eVTOL company's latest earnings report. Why investors are piling in even before commercial certification. Plus, stocks here at home aren't the only ones in rally mode.
29:32How developments in the Middle East could be giving global equities the go-ahead. You're watching Fast Money live from the NASDAQ market site in Times Square. Back right after this.
29:47Comcast is delivering extraordinary experiences in live sports. Through the incredible broadcast and storytelling from NBC, innovative and personalized viewing features on Xfinity and Peacock, and the country's most reliable Wi-Fi, viewers can enjoy every game-changing play faster and more seamlessly than ever. All on a network built to deliver unforgettable moments as close to live as possible. The ultimate experience for the American sports fan. Learn more at comcastcorporation.com slash sports. Never bet against American grit. or American energy. Through innovation, Venture Global is not only building some of the largest energy facilities in the world right here in the United States, but delivering American energy at a fraction of the cost and a fraction of the time.
30:36So while others are busy talking, we're busy building. That's Venture Global. That's unstoppable energy.
30:47The Second World War is the largest event in human history. A 20-part documentary series with Tom Hanks. No part of the globe was untouched. No life unchanged. Experience the ultimate account of World War II. Every single person had a story. These are the stories that make us who we are. World War II with Tom Hanks. New episode Monday at 8, part of History Honors 250, only on the History Channel. Welcome back to Fast Money. Joby Aviation flying 21 % after posting better-than-expected sales. Last night, the electric vertical takeoff and landing company, EBTOL, did see a bigger loss than expected for the quarter.
31:30Joby Aircraft aren't yet approved for commercial service, but the company expects to begin operations later this year. Reported revenues coming mostly from its acquisition of the Blade Air Taxi Service last August. Other EV toll stocks, such as Archer Aviation, Beta Technologies, and Ehang, also higher today. Grasso, you've been in this one. Yeah, so I'm in it through options now, and I've owned the equity as well. I think it was lumped in there with when the Trump administration came in, it was lumped in as an EV, and they thought all EVs were going to suffer under a Trump presidency because he was more fossil fuel focused.
32:04You know, this is a world away from an EV car. This is, and we've seen them. They did the presser going from New York City to JFK. It's really becoming tangible. They have the pre-cert. So as you said, the intro, they're looking for passengers back end of 2026. I think it's really they have partners with Toyota. They have partners with Delta. They have military contracts now. So this is not a what if. This is a when opportunity. And both of them are still under pressure. Right. Joby is down for the year. Archer is down for the year. I think there's a huge runway. not that they need one because they can do a vertical take off and landing and i think this is something where people are just going to start discovering them i'm in it now but i'm really fascinated with the with the spot you fly a lot you travel a lot not as much as i used to okay but yes yes i do i mean am i getting on one of these things not necessarily do i think it's a 10 billion dollar company on the back potentially of military contracts and defense alone yeah Sure, I think it could be.
33:06I mean, it's obviously early days and speculative. We're talking about a company that's basically pre-revenue still. Coming up, overseas opportunities to market seeing even bigger gains in the U.S. today and how to play the moves now. More on what is driving international stocks when Fast Money returns.
33:26Missed a moment of Fast? Catch us anytime on the go. Follow the Fast Money podcast. We're back right after this.
33:39Welcome back to Fast Money. Stocks surging and oil pulling back on optimism the U.S. and Iran are nearing an agreement to end the war. The Dow jumping more than 600 points. The S &P climbing 1.5 percent, closing above 7 ,300 for the first time. The Nasdaq leading to the gains, surging 2 percent. Those two indices both closing at record highs. WTI crude, meantime, dropping more than 7 percent, settling just above$95 a barrel. Uber driving higher today. Shares up 8.5 % after the rideshare company issued higher than expected bookings guidance. The stock's still down 3 % this year. CVS also getting a boost, jumping nearly 8%.
34:13The company blew past first quarter earnings and revenue estimates and raised the 2026 guidance thanks to improvement in its insurance business. And do not miss Jim's exclusive interview with the president and CEO of CVS. That is tonight on Mad Money at the top of the hour. Some more after hours action here. Arm Holdings and Apple 11 both topping earnings and revenue estimates snap lower as revenue comes in in line with estimates. DoorDash jumping after topping EPS expectations and Zillow beating estimates on the top and bottom lines. That stock, though, is lower. Meantime, global equities rallying along with U.S.
34:46stocks today. China, Japan, Germany and more jumping as investors hope progress in the Middle East could open the door for international market gains. China tech seeing particular strengths. Shares of Alibaba having their best day since January. I mean, there's a number of things going on here, Karen. Oil being down really helps relieve some of the pressure there with the hopes that the war is going to be over. The China tech trade is very interesting. The China tech trade is very interesting. They would be the beneficiary as well. All of Europe, right, this is a disaster for them. So, I mean, I think the DAX turned positive after today.
35:20So that's been a nice run. So I have exposure there. I have exposure in Mexico, which is somewhat more isolated. and Japan, which has some other machinations going on of the yen and, I mean, some wild swings. But I think that's all good for equities there. So I'm staying long that. Yeah. Yeah. I mean, a lot of Japanese companies remain quite cheap. Obviously, the tumult that's going on with the yen, though, can provide potential tailwinds for some of those companies. And so I think that's definitely a benefit. German stocks are up less than, what, 20 percent in the last five years. I mean, these things also are quite dirt cheap, and all of them have been completely suppressed by what's been going on geopolitically because they're more affected by it than we are.
36:00So they're importing more inflation. Everybody goes to the pump here all panicked about inflation. But these other places are importing a lot more inflation than we are because we produce, at least in barrels of oil equivalent, what we use. We were just talking about even if the war ended today, there's still going to be a bad—I mean, there's still so much shortage that is going on around the world in terms of production not coming back online, in terms of reserves. We need a billion barrels. We need a billion barrels. We were short 400 million in the SPR, call it 10 a day for two months coming through the Strait of Hormuz.
36:32This is a really big logistical problem. It's 6 ,000 miles from the Persian Gulf to get to Asia, where a lot of the shortages exist. So if you run a Singapore refinery, I mean, it's going to last while. So isn't the economic potential danger? I mean, they still exist, though, I mean, if the war ends today. So the energy shock absorber has been completely compressed. There's pretty much nothing left. But the flip side of it is that a lot of these areas, like the things that Karen's invested in, have already been compressed themselves so much that I kind of feel like that damage is baked into the cake.
37:01And the good news is the market always looks through these things, right? So the market always looks through six, eight months and looking towards, if you look at the back end of the curve, it's lower. And then also when you talk about Alibaba, we have the Trump Xi meetings next week. So that's going to be a catalyst to it. And I think Trump is playing it nice with Iran and playing a little more passive ahead of those meetings. You could see if those meetings go bad, the China tech trade comes off the table and the market maybe comes back in. Coming up, trimming weight but packing on the profits.
37:29How would Gobi pill sales are fueling a long lagging Novo Nordisk and what it could mean for the pharma company's bottom line. Mizzou host Jared Holes will join us next to dig into it all when Fast Money returns.
37:46Welcome back to Fast Money. Novo Nordisk rising 2 % after reporting strong Q1 sales bolstered by its Wegovi pill. The company raising guidance and now expects a smaller decline in full-year sales and profit. Though still trailing Eli Lilly in stock performance, Novo is leading in prescriptions for its pills, saying over a million people have accessed oral Wegovi since January. Lilly said last week over 20 ,000 people have started on its Fondeo pill since April 1st. That's its launch date. For more, let's bring in Mizuha, a health care specialist here at Holstier. Great to have you with us. Thank you.
38:17Appreciate it. Did you think it was a good report? Yeah, I did. I mean, I think when you look at sort of on balance what's going on at Novo and the launch of the oral, plus, you know, we go in general looking pretty solid and the stock at multi-year lows, I thought it was pretty good. Yeah. Do you think that there is going to be this catch-up trade that continues? I mean, I think what's interesting about Eli Lilly is that, you know, the full sort of campaign direct-to-consumer hasn't started yet. And I just wonder, you know, when people start understanding what Fondeo is, which is a brand new name for a drug, they might actually try it.
38:59Yeah, I think both of these drugs are going to be very big. I mean, the market, I think, over time will probably wind up migrating towards oral. It's easier. Oral therapies in pharma and biotech tend to do very well for obvious reasons. It's a lot simpler, especially if you're averse to the weekly injections. And so I think we're on the precipice of blockbusters for both companies. I think the Novo Nordisk launch is probably the most unheralded drug launch that I can remember. I mean, two million prescriptions written within four, maybe a little bit over four months is kind of unheard of. And so I'm still really surprised that the street hasn't rallied around it more.
39:45But, you know, it's going to take time for sentiment in this stock to improve, just given years of disappointment. It's Karen. Thanks for being on. I mean, maybe that's just the way they do it in Denmark. very low key. They don't really want anyone to know. I'm not sure. But if you could advise them to, you know, clearly they traded a discount of 50 percent of the Lilly valuation. Granted, Lilly has some other things, but if you could advise them, what would you tell them to do? Well, I think it's just all about getting new patients onto the oral drug and hoping that the, you know, the efficacy and the tolerability for most patients are good.
40:20And And once you get a new patient on one of their drugs, they're more than likely to stay barring some reimbursement change. So I think the fact that you have a couple million people on the drug is a really good start. I think just attack the market, obviously drive the commercial success of the drug and not prevent Lilly from doing well, but at least get, you know, 50 percent market share in the oral market and then worry about the pipeline and do some deals. But I just think it's about getting that incremental patient on drug and keeping them on so that you can, you know, own the market here for a while.
41:01So, Jared, when I look at the three year charts on both of these, it's a no brainer. It doesn't look like it doesn't look like Novo is going to do anything to catch up to Lilly, even even though the headlines can be positive for that. When you sit in your seat, look through the M &A and you look through the patent cliff happening, what's your most exciting name as we're coming to the close on the interview? Well, I'm kind of just excited to see what Nova Nordisk does. I mean, they could do a variety of things in cardiometabolic for sure. They keep on talking about obesity as something they want to continue to add to, sort of alluding to the fact that they don't think their pipeline is complete.
41:42So I think, you know, looking across the spectrum of what they could buy in cardiometabolic, there's a bunch of companies that sort of would fit that profile. We've talked about Structure before, Cytokinetics, Ascendis. There's a bunch of things that they could potentially buy. I mean, those are three of hundreds of potential deals they could do. I don't have like a, you know, a name that they need to be buying. But I think that they're very forthcoming that they're going to be a buyer. And there's a lot to choose from. I think it just sort of like underscores the environment that we're in for business development in general.
42:17You know, the CEO of Novo had some interesting comments about how they decided to go with their form, peptide versus small molecule, which is what Eli Lilly and a lot of other competitors have gone through. It's much easier to manufacture the small molecule. But in the end, the route that Novo has chosen will be the way. I mean, it's more effective in terms of weight loss, et cetera. Do you agree that in the end that that will prove to be a superior treatment that doctors is that what is behind the discrepancy in Scripps right now, do you think? I don't really know. I mean, the small molecule that that Lily is developing and selling, I think, is logistically easier.
42:58Yeah. Peptine manufacturing is something that Novo has an expertise in. So I think they've been able to do a really good job and they were first to market here. I think, you know, we often forget that when they launched the injectable, they had supply constraints right off of the bat. That doesn't seem like it's the case here. I don't know whether it's better. Really, really hard to say. I think both of these drugs can be blockbusters and we'll see what happens. Right. Jared, thanks for joining us. Always great to speak with you. Jared Holtz. Feeling better about your Novo now, huh? Yes. I added some more, so that was good.
43:32But, I mean, it's still got a long, long way to go. If I own none, I came to it today right here. I would buy it. Yeah. How about you? Yeah. Same thing. Bought it early, actually. I thought 55 was a pretty nice level to start getting into it. I mean, look, you have a nice margin of safety at the valuation and the cash flow. Yeah, for sure. Coming up, what options traders are ordering up for McDonald's ahead of its earnings report tomorrow morning and whether the fast food chain can deliver when results cross the wires. More Fast Money in two.
44:08Welcome back to Fast Money. We are setting the table for McDonald's earnings tomorrow before the open. The fast food stock hitting its lowest level since last January, now down 7 percent so far this year. Options traders are betting we could see a big move after results hit. Mike, what do you see? Yeah, I mean, big for McDonald's, not big relative to some of the names that we've been talking about a lot already today. This is not one that typically moves very much after earnings, about 2 % on average. Right now, the options market is implying almost two times that amount. But today's flow, kind of like the stock itself, was bearish.
44:39The most active contracts were the week-ending 270 puts. We saw about 3 ,000 of those trading. Puts traded over all about three times their average daily put volume. So right now, it seems like the pressure remains. Yeah. I mean, gas prices are a huge problem. Gas prices are a problem. Beef prices are a problem. They're really great at managing their SKUs, the items that they sell. They're really great at monetizing the drive-through. And this is an area, you go back a year, where the stock did start to base. So I'd be willing to take a shot here. I think they're going, drinks, our margins on drinks are 85%.
45:14So I think you're going to see a huge push coming into summer with drinks. Maybe they can make a margin there that they're losing in beef. Well, they have a whole beverage menu, right? Energy drinks, in addition to all the coffee that they're selling. And of course, that, I mean, then you're talking Starbucks territory a little bit. No protein drinks yet? I don't think so. I bet that's in the offing at some point. They grind the nuggets into a... Disgusting. I mean, it's a market-ish multiple. Probably deserves something better than that, but I just haven't been that interested in it. I mean, at some point you think if a consumer is really under stress, maybe you go to McDonald's.
45:54You know, the thing that McDonald's always had going for them in an an inflationary environment was because of their models or the franchise model that their royalties racked with the inflation price, but their expenses didn't necessarily go the same way. And so that was kind of a benefit. Seeing them now at slightly below a market multiple, better than 5 % free cash flow yield, I think it's OK. How about that? All right. The food, better than the food, maybe. Depends if you're five. Next, Final Trades.
46:31Final trade time, Karen. Yes, so OIH, every time oil drops, I'm going to buy some more. And happy birthday to Tim Seymour today. Timote. Timbo. Micah. Happy birthday, Tim. Returning to profitability in the next year, Honda Motor. HMC. Steve. Corning. Update today. Might give a little bit back, but I think ultimately pops over$200. Thanks for watching fast. See you back here tomorrow at 5. Mad Money. Jim Cramer starts right now. All opinions expressed by the Fast Money participants are solely their opinions and do not reflect the opinions of CNBC or its parent company or affiliates and may have been previously disseminated by them on television, radio, internet, or another medium.
47:07You should not treat any opinion expressed on this podcast as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion. Such opinions are based upon information the Fast Money participants consider reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. To view the full Fast Money Disclaimer, please visit cnbc.com forward slash Fast Money Disclaimer.
47:53their OSA. ZetBound is approved as a 2.5, 5, 7.5, 10, 12.5, or 15 milligram injection. ZetBound contains terzepatide and should not be used with other terzepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if ZetBound is safe and effective for use in children. Don't share needles or pins or reuse needles. Don't take if allergic to it or if you or someone in your family had medullary thyroid cancer or if you've had multiple endocrine neoplasia syndrome type 2. Tell your doctor if you get a lump or swelling in your neck. Stop ZipBound and call your doctor if you have severe stomach pain or a serious allergic reaction.
48:30Severe side effects may include inflamed pancreas or gallbladder problems. Tell your doctor if you experience vision changes before scheduled procedures with anesthesia. If you're nursing, pregnant, plan to be, or taking birth control pills. Taking ZipBound with a sulfonylurea or insulin may cause low blood sugar. Side effects include nausea, diarrhea, and vomiting, which can cause dehydration and worsen kidney problems. Talk to your doctor. Call 1-800-545-5979 or visit setbound.lily.com.
From the publisher
Semi stocks on a tear, as AMD surges after earnings, and Nvidia powers the market higher after a partnership with fiber optics maker Corning. The latest chip trends leading the trade, and how much more these stocks can climb. Plus Some Disney magic after reporting, Joby Aviation takes off, and a global go-ahead… how progress in the Middle East is giving overseas markets room to run.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
